click below
click below
Normal Size Small Size show me how
IOS 11 Exam 1
Antifungal Pharmacology/Drug Interactions
| Question | Answer |
|---|---|
| What are targets for antifungal medications (7) | membrane dysruption, ergosterol synthesis inhibitors, nucleic acid inhibitor, anti-mitotic, Glucan synthesis inhibitors, Chitan synthesis inhibitors, Protein synthesis inhibitors |
| Nystatin MOA | Bings ergosterol in fungal cell membrane & alters membrane permibility releasing intracellular K, sugars, and metabolites |
| Nystatin- SE | nausea, vomiting, diarrhea, and Gi discomfort |
| Nystatin spectrum of activity | Fungicidal- Oral candidiasis, mucocutaneous infections, gut decontamination |
| Amphotericin B- MOA | Binding to ergosterol leading to intercalation of cell membrane causin leakage of K, sugars, and metabolites |
| Amphotericin B- ADME | Insoluble in water, not absorbed, 95% protein bound, biphasic elimentation via bile and feces t=1-2 days and t2=several |
| Amphotericin B PD | Concentration dependant |
| Amphotericin B DI | Other nephrotoxins and agents that effect electrolytes |
| Spectrum of activity of Amphotericin B | Candida spp. Aspergillus, Cryptococcus neoformans, Mucor, Blastomyces dermatitidis, Histoplasma capsulatum, Paracoccidioides |
| Griseofulvin MOA | Inhibits the spindle and cytoplasmic microtubule function--Old drug we do not use |
| Azoles MOA | Bind C-14 alpha demethylase blocking the conversion of lantosterol to form ergesterol |
| Fluconazole ADME | Good absorption, Complete distribution, Renal elimination |
| Posasonasole ADME | 400mg of Absorption max, highly protein bound, and hepatic clearance |
| Azoles PD | Time dependant |
| Voriconazole DI's | many- Rifampin, phenytoin, carbamezepine, phenobarbital, warfarin, loratidine, protease inhibitors, chemotheraputics |
| Fluconazole spectrum of activity | Candida, cryptoccus neoformans, histoplasma, balstomycosis, coccidimycosis |
| Voriconazole specturm of activity | Candida, cryptoccus neoformans, histoplasma, balstomycosis, coccidimycosis, Fusarium, Scedosporium |
| Posaconazole spectrum of resistance | Candida, cryptoccus neoformans, histoplasma, balstomycosis, coccidimycosis, Fusarium, Scedosporium, Zygomycetes |
| Flucytosine MOA | Inhibition of cytosine deaminase which is intrinsic only in fungi. Leads to decrease in 5FU and decrease in DNA synthesis. |
| Flucytosine ADME | Oral form- good distribution,low protein binding, great distribution, renal elimination, Monitor serum levels |
| Fungistatics are | Azoles, Flucytosine |
| Fungicidals are | Nystatin, Amphotericin B, Caspofungin, nikkomycin |
| Crytpotoccal meningitis Combination therapy | Flcytosine + Amphotericin B |
| Trichosporon Combination therapy | Fluconazole +Amphotericin B |
| Azole + AmB | In theory not an ideal combination. Azole depletes ergosterol and AMb needs ergosterol. |